Osteoporotic fracture risk ‘lower with NOACs than warfarin’
Observational study from Hong Kong shows little to choose between three non-vitamin K oral anticoagulants
The risk for osteoporotic fractures among patients with atrial fibrillation is substantially lower with non-vitamin K oral anticoagulants (NOACs) than with warfarin, an observational study shows.
Researchers from the UK and Hong Kong examined data from the Hong Kong Hospital Authority on more than 23,500 new users of anticoagulants, including 14% treated with apixaban, 29% treated with dabigatran, 16% treated with rivaroxaban and 41% treated with warfarin.
